In 2005, the rate of macrolide resistance among GAS was estimated in France to be between 16% and 31%; however, no ad hoc epidemiological study had previously attempted to refine this...

Introduction – In response to the resurgence of invasive group A streptococcal infections (IGASIs) in late 2022, healthcare professionals were encouraged to report all hospitalized IGASI...

In October 2016, Santé publique France launched the first edition of the "Mois sans tabac" initiative, inspired by the British Stoptober campaign, with the primary goal of encouraging...

Introduction – This article presents a summary of the epidemiological and virological data from the influenza epidemic that occurred in France during the 2023–2024 season. Methods – The...

Introduction – This study describes mortality by cause of death in 2022, comparing its trends with those observed between 2015 and 2019 and in 2020 and 2021. Methods – Using death...

Introduction – The elimination of viral hepatitis and the prevention of HIV transmission are key objectives of global and national health strategies. The collection of blood drops on...

Among patients who are carriers of the hepatitis B virus (HBV), 5% are infected with the Delta virus (HDV) and face a particularly high risk of cirrhosis and hepatocellular carcinoma...

Introduction – This article analyzes hepatitis B and C screening and diagnostic activities at the free centers for information, screening, and diagnosis of human immunodeficiency virus...

Introduction – In France, health authorities have received several reports of hygiene violations in dental offices. This article describes the screening campaign for bloodborne viruses...